Mablink Bioscience
Benoit Joseph's work experience begins in 1994 when they started working as a Maître de Conférences at Université d'Orléans. Benoit held this role until September 2001. In October 2001, they joined Université Claude Bernard - Lyon 1 as a Professeur d'Université and continues to work there to this day. Additionally, in December 2018, Benoit Joseph became a Co-Founder of Mablink Bioscience.
Benoit Joseph completed their education in a chronological order as follows:
From 1989 to 1992, they attended Université d'Orléans and obtained a Doctorat degree in the field of study of Chimie Organique.
This person is not in any offices
Mablink Bioscience
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).